Table 4.
The analysis of significant pathway enrichment
| Term | Description | Count | LogP |
|---|---|---|---|
| R-HSA-1640170 | Cell cycle | 21 | −9.543 |
| R-HSA-69620 | Cell cycle checkpoints | 12 | −7.004 |
| R-HSA-216083 | Integrin cell surface interactions | 7 | −6.318 |
| R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 5 | −4.237 |
| R-HSA-4615885 | SUMOylation of DNA replication proteins | 4 | −3.946 |
| R-HSA-5173105 | O-linked glycosylation | 5 | −3.408 |
| R-HSA-421270 | Cell-cell junction organization | 4 | −3.352 |
| R-HSA-202733 | Cell surface interactions at the vascular wall | 5 | −2.993 |
| R-HSA-196854 | Metabolism of vitamins and cofactors | 5 | −2.375 |
| R-HSA-193648 | NRAGE signals death through JNK | 3 | −2.365 |
| R-HSA-983189 | Kinesins | 3 | −2.365 |
| R-HSA-69275 | G2/M Transition | 5 | −2.319 |